Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 10, 2016
|
| In: |
The lancet
Year: 2016, Volume: 387, Issue: 10028, Pages: 1629-1637 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(15)01283-0 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/S0140-6736(15)01283-0 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0140673615012830 
|
| Author Notes: | Patrick Schöffski, Sant Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar R. Patel |
| Item Description: | Gesehen am 07.11.2019 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(15)01283-0 |